Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)

Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)

Abstract Background Functional impairment affects many patients with schizophrenia. Treatment with the long-acting injectable antipsychotic aripiprazole once-monthly (AOM) may help improve functioning. Objectives To explore changes in functioning in patients with schizophrenia who received AOM treat...

Full description

Bibliographic Details
Main Authors: Oloruntoba Oluboka, Guerline Clerzius, Wolfgang Janetzky, Daniel Schöttle, François Therrien, Klaus Wiedemann, Marc-André Roy
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Psychiatry
Subjects:
Schizophrenia
Long-acting injectable
Observational study
Real-world evidence
Aripiprazole once-monthly
Functioning
Online Access:https://doi.org/10.1186/s12888-023-04893-8

Internet

https://doi.org/10.1186/s12888-023-04893-8

Similar Items